A single treatment of viral vector-delivered CAR-A construct in mice with existing plaque saturation cut the amount of amyloid plaques in half.
A new study reveals that astrocytes—star-shaped support cells traditionally viewed as passive partners of neurons—play a ...
The new generation of Alzheimer's disease drugs—the first proven to change the course of the disease—typically extend independent living for patients by 10 months. Called monoclonal antibodies, they ...
Scientists have developed a promising new approach to treating Alzheimer’s disease by turning ordinary brain cells into powerful plaque-clearing machines. Instead of requiring frequent antibody ...
Astrocytes shed their supportive role and unlock hidden neurogenic potential, offering new hope for brain injury recovery through cutting-edge epigenetic reprogramming. Study: DNA methylation controls ...
Researchers engineer CAR-astrocytes to target and remove amyloid plaques in Alzheimer’s, showing a 50% reduction in brain ...
Astrocytes in the cerebellum trigger a shift in GABA signaling during late adolescence, enabling adult-level motor coordination.
The connection between perturbations in BBB barrier function and damage to the astrocyte network and its functions arises from BBB damage, leading to the extravasation of albumin. In the physiological ...
Morning Overview on MSN
Engineered cells slash brain amyloid plaques by 50% in mice study
Scientists at Washington University in St. Louis have engineered brain cells to hunt and destroy amyloid plaques, cutting toxic buildup by roughly half in aged mice with advanced Alzheimer’s-like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results